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Tom Hesterberg, a great friend and colleague, suffered
an untimely death in August, 2016. I met Tom in the
first half of 1981. I had recently arrived in the Fall of
1980 at the National Institute of Environmental Health
Sciences (NIEHS) as a postdoctoral fellow. The NIEHS
Branch Chief of the Laboratory of Pulmonary Function
and Toxicology at that time, Dr. Paul Nettesheim, had
arranged for Tom and I to have dinner at Darryl’s res-
taurant in Chapel Hill, NC to discuss a funding pathway
to bring Tom to NIEHS. I remember our first meeting
almost like it occurred yesterday. From the outset, I was
very impressed with Tom’s friendliness, intelligence, and
convivial personality. Working with Dr. Carl Barrett,
Tom wrote and submitted an NIH grant application, de-
signed to investigate potential mechanisms of asbestos-
related carcinogenicity, and subsequently was awarded
the highest priority score in that NIH postdoctoral grant
cycle. It was important that Tom, in receiving this extra-
mural NIH grant, achieve success in bringing his own
funds to NIEHS. Tom also had great success in his years
at NIEHS and published several important papers, (in
Cancer Research, Carcinogenesis, and other journals)
related to mechanisms of asbestos-mediated carcinogen-
esis. I believe that Tom was a major contributor in
launching Carl Barrett’s Laboratory into the forefront of
fibre carcinogenesis research.
Following his successful experience at NIEHS, Tom
accepted a position as visiting scientist in the Genetic
Toxicology Department at the Chemical Industry Insti-
tute of Toxicology (CIIT). During his tenure at CIIT,
Tom developed a human bronchial epithelial cell culture
system to be utilized for in vitro carcinogenesis studies.
A number of publications in the journal Carcinogenesis
are reflective of his scientific productivity while at CIIT.
Based upon his research experiences at NIEHS and
CIIT, Tom was well positioned to join the Johns Manville
Company during a critical period when the company and
industry in general were contemplating conducting fibre
toxicity research with a variety of man-made vitreous
fibre-types. Without a doubt, Tom led the international
industry effort to assess the safety of these synthetic
inorganic fibre-types in what became known as the ‘RCC
studies’. In this regard, he was the scientist primarily
responsible for designing the subchronic and chronic
inhalation studies. He took the lead as a study monitor to
ensure that the studies were conducted in a competent
and exemplary fashion. In addition, he developed and
standardized methodologies for counting and sizing fibres
retained from the lungs of exposed animals and innovated
new in vitro systems for assessing the likelihood of bioper-
sistence of synthetic fibre-types in vivo. Tom published
and presented both the in vivo and in vitro study results
in numerous journals and international forums and these
had a profound influence on regulation and indeed set the
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studies with fibres. Tom was widely recognized for his
expertise in fibre toxicology. Tom was an effective pro-
ponent of the structure/toxicity relationship that emerged
from the totality of the RCC studies and that has domi-
nated fibre toxicology ever since. This concept is that
inhaled fibres of low durability or biopersistence produced
significantly less hazard or risk to workers/consumers
when compared with inhalation exposures to durable or
biopersistent fibres such as asbestos or other forms of
durable man-made fibre-types.
A major impact of Tom’s research efforts in the RCC
studies was the 2001 decision of an International Agency
for Research on Cancer (IARC) panel to classify biosolu-
ble man-made vitreous fibres as “not classifiable to
human carcinogenicity”. Based on his extensive pub-
lished research findings in the field, Tom was selected by
IARC to serve on the review panel. That was in itself a
noteworthy achievement recognizing that scientists
employed in industry are not often requested to serve
on IARC panels.
Following his experience with man-made mineral
fibres, Tom spent 10 years at Navistar, Inc. the largest
manufacturer of trucks and engines in the United States,
where he served as Director of Product Stewardship,
Sustainability and Environmental Health. At Navistar, he
oversaw the evaluation of the potential health, safety and
environmental risks related to the use of diesel trucks
and engines. Following his tenure at Navistar, Tom
served as a Principal Toxicologist at the Center for
Toxicology and Environmental Health.
On a more personal note, Tom’s curriculum vitae and
bibliography were very impressive. He published over
100 scientific papers and was a recognized expert in
fibre and particle toxicology, serving on numerous
expert scientific panels. Tom’s efforts and accomplish-
ments provided a significant positive impact on the field
of toxicology and were highly regarded by scientific
regulators, both in the US, Europe and Australia as well
as with academic and industrial colleagues. In 2006,
Tom was awarded the prestigious Career Achievement
Award by the Society of Toxicology, Inhalation Specialty
Section. He served on several editorial boards of leading
toxicology journals and numerous national and inter-
national scientific panels. Tom was very bright, gregari-
ous and engaging, with a great smile. He was an
intellectually curious individual who was highly moti-
vated, friendly, with diverse, eclectic interests; as well as
a life-long learner, evidenced by the fact that he had
attained an MBA while working as a Toxicology Director
at the Johns Manville Company.
I will miss my good friend Tom Hesterberg, and he
will be missed by the entire particle and fibre toxicology
community.
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